Novel nonaromatic fluoroallylamines are potent MAO inhibitors and at low dose selectively inhibit MAO-B. They are useful in the treatment of depression and co-administration with L-dopa and decarboxylase inhibitors, in the treatment of Parkinsonism.
新型非芳香族
氟丙烯胺是有效的MAO
抑制剂,低剂量下选择性抑制MAO-B。它们可用于治疗抑郁症,并与L-
多巴胺和脱羧酶
抑制剂联合使用,用于治疗帕
金森病。